Athens, Ga -- The risk of using viruses to deliver gene therapy might soon be eliminated thanks to a U.S.-developed non-viral synthetic delivery method.
University of Georgia Assistant Professor Yan Geng and colleagues say they've created a synthetic gene vector that packages DNA into well-defined nanostructures, allowing it to deliver genes without triggering immune responses.
"We've developed a very versatile approach to creating synthetic gene delivery vectors," said Geng. "Our approach is relatively simple -- using simple chemical reactions to create a new class of packaging molecules that wrap up genes on their own -- and has the potential to be very useful in real-world, clinical applications.
"These gene vectors also can be further conjugated with targeting molecules, which will allow us to deliver the right genes to the right spot in our body," Geng added. "Our research is still at an early stage, but we've developed a very promising system."
The study, primarily conducted by doctoral student Jennifer Haley, appears in the journal Molecular BioSystems.
Disclaimer: The views and investment tips expressed by investment experts on themoneytimes.com are their own, and not that of the website or its management. TheMoneyTimes advises users to check with certified experts before taking any investment decision.
Recent comments
18 hours 5 min ago
1 day 54 min ago
1 day 56 min ago
1 day 3 hours ago
1 day 4 hours ago
1 day 21 hours ago
2 days 10 hours ago
3 days 19 hours ago
1 week 12 hours ago
1 week 16 hours ago